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Comparing febrile children presenting on
and off antibiotics to the emergency
department: a retrospective cohort study
R. D. Sawaya1, T. El Zahran1, S. Mrad1, C. Abdul Massih1, S. Shaya2, M. Makki3, H. Tamim3*† and M. Majdalani4*†

Abstract
Background: It is not yet known how antibiotics may affect Serious Bacterial Infections (SBI). Our aim is to describe
the presentation, management, and serious bacterial infections (SBI) of febrile children on or off antibiotics.
Methods: Retrospective, cohort study of febrile Emergency Department patients, 0–36 months of age, at a single
institution, between 2009and 2012.
Results: Seven hundred fifty-three patients were included: 584 in the No-Antibiotics group and 169 (22%) in the Antibiotics
group. Age and abnormal lung sounds were predictors for being on antibiotics (OR 2.00 [95% CI 1.23–3.25] and OR 1.04 [95% CI
1.02–1.06] respectively) while female gender, and lower temperatures were negative predictors (OR 0.68 [95%0.47–0.98] and OR
0.47 [95% CI 0.32–0.67] respectively). Antibiotics were prescribed by a physician 89% of the time; the most common one being
Amoxicillin/Clavulanic Acid (39%). The antibiotic group got more blood tests (57% vs 45%) and Chest X-Rays (37% vs 25%). Overall,
the percent of SBIs (and pneumonias) was statistically the same in both groups (6.5% in the No-antibiotic group VS 3.6%).
Conclusions: Children presenting on antibiotics and off antibiotics were significantly different in their presentation and
management, although the overall percentages of SBI were similar in each group. Further investigations into this subgroup of
febrile children are needed.
Keywords: Febrile children, Serious bacterial infections, Antibiotic use

Background
Children with fever constitute a substantial proportion
of ambulatory emergency department (ED) visits [1].
Serious bacterial infection (SBI) rates are still elevated:
up to 12.8% in febrile infants less than 60 days of age [2],
and up to 7.2% in children less than 5 years of age [3]. In
the 1990s, several studies developed prediction rules to
identify SBI in febrile infants [4–7]. Many have been
revisited as the bacterial landscape has changed
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especially with the advent of vaccines [8–11]. However,
as antibiotic use may alter the patients’ microbiome [12]
and test results [13], including cultures [14], febrile children on antibiotics are typically excluded from studies
on SBI [4–11]. In fact, there is no data describing febrile
children presenting to the ED on antibiotics, nor the
type of SBIs they may present with. Therefore, it is unclear how to use the data on SBI predictors and diagnosis in this subpopulation of febrile children already.
The objective of this study was to describe previously
healthy children, presenting to the ED with fever, stratified by previous antibiotic use or not; and to describe
the distribution and types of SBI in those two groups.

© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.

Sawaya et al. BMC Pediatrics

(2020) 20:117

Methods
Study design

We carried out a retrospective, cohort study of patients
0–36 months of age presenting with fever to the ED of
the American University of Beirut Medical Center in
Beirut, Lebanon, between July 1, 2009 and June 30, 2012.
Institutional Review Board approval was obtained. This
is an ED of a tertiary care center, in a middle-income
country where pediatric patients during the time of our
data collection where seen primarily by pediatricians
with or without intensive care training.
Population

We included all patients 0 to 36 months of age, with
fever (rectal temperature ≥ 38 °C or ≥ 37.6 °C by any
other route) measured in the ED, at home or at the pediatrician’s office. We retrieved the records of patients
with one or more of the following chief complaints, ED
discharge diagnoses or hospital admission/discharge
diagnoses: fever, cough, sore throat, runny nose, fussy,
lethargy, decreased activity, seizure activity, vomiting,
diarrhea, pneumonia, urinary tract infection (UTI), viral
illness, tonsillitis, pharyngitis, cellulitis, abscess, meningitis, encephalitis, sepsis, septic shock, bacteremia.
We excluded all patients with an underlying immunosuppressive disease or immunosuppressive medication;
with an underlying chronic disease (that may impact
fever management); with a previous UTI; and admitted
to the ED or hospital within the last 2 weeks.
Data collection

We included information on: patient demographics, clinical presentation, and management. Data was collected
by 4 physicians who had a training by the principle investigator in order to use the same terminology and
categorize signs and symptoms in the same way.

Definitions
We defined Serious Bacterial Infection (SBI) as one of
the following:
1- Urinary Tract Infection: a positive urine culture >
5000 cfu/ml for suprapubic aspiration (SPA), >
10,000 cfu/ml for a sterile catheterization in
children < 2 months old; > 50,000 cfu/ml AND
pyuria by urinalysis (WBC > 5/mm3) by sterile
catheterization or SPA and > 100,000 cfu/ml for
clean catches [2, 15].
2- Bacteremia: a positive bacterial culture with a true
pathogen other than Coagulase Negative
Staphylococcus or other commensal bacteria (such
as Staphylococcus epididymis and Diphteroid),
which were considered contaminants unless treated
as true infections per documentation [2, 7, 16, 17].
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3- Meningitis: a positive cerebrospinal fluid culture
other than coagulase negative Staphylococcus
which was considered a contaminant, unless treated
as true infections per documentation [2, 18].
We defined Pneumonia as a Chest X-Ray reported by a
radiologist as definite or probable for a pneumonia (“Infiltrate”, “consolidation” or “concerning for developing pneumonia”) irrespective of microbiological results as these are
low yield [19]. This definition reflects clinical practice.
We defined tachypnea and tachycardia as values above
the upper limit of normal for age, as per Additional file 1.
We defined hypoxia as an oxygen saturation ≤ 97%.
We defined abnormal perfusion as any documentation
of mottled skin, or capillary refill greater than 3 s, or a
flash capillary refill consistent with possible warm shock.
The “Antibiotic” group included all children who were
on antibiotics prior to the ED visit as per care giver’s report or who had received antibiotics within the past 2
weeks. The “No-Antibiotic” group included the children
who had not received any antibiotics prior to the ED visit.
Statistical analysis

The Statistical Package for Social Sciences (SPSS), version
24.0 was used for data cleaning, management and analyses. Descriptive statistics were summarized by presenting
the number and percentage for categorical variables,
whereas continuous ones were presented by mean and
standard deviation (±SD). In the bivariate analysis, the association between antibiotic use and other categorical variables was assessed using Chi-Square test, whereas
Student’s t-test was used for the association with continuous variables. Multivariate regression analysis was used to
adjust for potentially confounding variables. Variables
which were statistically significant in the analysis or clinically important were included in the multivariate analysis.
The stepwise logistic regression analysis assessed the association between antibiotic use and the different predictors.
P-value of 0.05 was set for the entry of potential predictors
into the model, whereas a p-value of 0.1 was set for removal from the model. The results were presented by the
odds ratio (OR) and 95% confidence interval (CI). P-value
of < 0.05 was considered statistically significant. Missing
data was left empty.
The datasets analyzed during the current study are available from the corresponding author on reasonable request.

Results
We retrieved 1427 patients from the medical records;
753 met our inclusion criteria and were analyzed: 584 in
the No-Antibiotics group and 169 (22.4%) in the Antibiotics group (Fig. 1).
As per Table 1, children in the Antibiotic group were
significantly older (21.2 months ±9.2 compared to 16.9 ±

Sawaya et al. BMC Pediatrics

(2020) 20:117

Page 3 of 8

Fig. 1 Flow chart of included patients. * Fever: T (R) ≥ 38, Tax ≥37.6. **Includes Oncologic, Cardiac, Kidney or Liver disease, Inflammatory Bowel
Disease, Sickle Cell disease, Insulin Dependent Diabetes Mellitus, Metabolic disease

10.3; p < 0.0001), in fact none of the children < 90 days
of age had received antibiotics prior to presentation in
this sample. In addition, the Antibiotic group was mostly of
male gender (62.7% compared to 51.4%, p < 0.009), and had
a longer duration of fever prior to presentation (4.5 days ±5.5
compared to 2.1 ± 1.6, p < 0.0001). Interestingly, associated
symptoms presented as frequently in both groups except for
a sore throat: 10.1% in the Antibiotic group compared to
4.8% in the No-Antibiotic group (p = 0.01) (Table 1).
The specifics of the antibiotic use within 2 weeks prior
to presentation to the ED with a fever were quite varied in
the Antibiotic group. The majority, (82%) were still takings antibiotics at presentation; and 10.8% were taking
multiple. The mean days of antibiotic use was 3.5 ± 3.0
days. The antibiotic was prescribed by a Medical Doctor
in 89.3% (101/113) of the cases. Finally, the most common
antibiotic used was an oral 3rd generation cephalosporin
at 33.2% followed by a combination of penicillin/beta-lactamase inhibitor at 31.9%.. Interestingly, up to 10.2% had
received intravenous (IV) or intramuscular (IM) 3rd generation cephalosporin,, prior to the ED visit.
When comparing the two sub-groups (Table 1), we
noted that the Antibiotic group was more likely to be
tachycardic (84% compared to 53.2%; p < 0.0001); to

have abnormal lung sounds (20.1% compared to 10.4%;
p = 0.001), an abnormal tympanic membrane (27.1%
compared to 18.8%; p = 0.02); and abnormal tonsils
(59.1% compared to 48.5%; p = 0.02). While the NoAntibiotic group were more likely to have an abnormal
mental status (12.2% compared to 6%; p = 0.02) and to
be looking more sickly (4.8% compared to 0; p < 0.001).
The Antibiotic group was more frequently tested by
blood work (56.8% compared to 45.0%, p = 0.01) and
chest radiography (37.3% compared to 24.7%, p = 0.001)
(see Table 2). But when tested, the No-Antibiotic group
had more bandemia than the Antibiotic group (mean
0.9 ± 5.0 compared to 0.1 ± 0.6, p = 0.02); a more frequently positive urine analysis (positive leukocyte esterase in 31.8% compared to 9.4%, p = 0.01 and positive for
WBCs in 23.8% compared to 6.3%, p = 0.03) and to have
influenza (p = 0.03). Interestingly, the frequency of fluid
boluses and admissions was the same in both groups.
In the multivariate analysis reported in Table 3, age,
and abnormal lung sounds were predictors for being on
antibiotics. In fact, each 1 month increase in age increased the odds of being on antibiotics by 1.04 (95% CI:
1.02–1.06). Finally, of all the patients, 5.8% had at least
one SBI. When analyzed by Antibiotic vs. No-Antibiotic
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Table 1 Variables in the history and physical exam associated with patients 0–36 months of age presenting to the ED with fever,
previously on and off antibiotics
All
N = 753

ABN = 584

AB+
N = 169

P-Value

Age (months), mean(±SD)

17.8 ± 10.2

16.86 ± 10.26

21.22 ± 9.18

< 0.0001

Male

406 (53.9)

300 (51.4)

106 (62.7)

0.009

Fever Duration (days), mean(±SD)

2.9 ± 3.5

2.14 ± 1.64

4.55 ± 5.54

< 0.0001

Congestion, yes

251 (33.4)

196 (33.6)

55 (32.7)

0.83

Immunizations up to date for age, yes

259 (97.7)

235 (97.5)

24 (100.0)

1.00

At least one of the below symptoms

664 (88.4)

509 (87.3)

155 (92.3)

0.07

Respiratory Symptoms

416 (55.4)

323 (55.4)

93 (55.4)

0.99

Gastrointestinal Symptoms

332 (44.2)

253 (43.4)

79 (47.0)

0.40

Urinary Symptoms

11 (1.5)

10 (1.7)

1 (0.6)

0.47

Sore Throat

45 (6.0)

28 (4.8)

17 (10.1)

0.01

Otalgia

31 (4.1)

25 (4.3)

6 (3.6)

0.67

Rash

36 (4.8)

29 (5.0)

7 (4.2)

0.67

Decreased Appetite

285 (38.2)

223 (38.6)

62 (36.9)

0.69

Decreased Urine output

67 (9.3)

56 (10.1)

11 (6.5)

0.16

Decreased Activity

120 (16.3)

94 (16.5)

26 (15.5)

0.75

Change in mental status

118 (15.7)

84 (14.4)

34 (20.2)

0.07
< 0.0001

ED Tmax a (°C) < 38

243 (32.3)

161 (28.4)

83 (49.7)

38–39.4

353 (46.9)

298 (52.6)

55 (33.3)

> 39.5–40

99 (13.1)

78 (13.8)

21 (12.7)

> 40

37 (4.9)

30 (5.3)

7 (4.2)

Tachycardia (n = 291)

201 (69.1)

75 (53.2)

126 (84)

< 0.0001

Tachypnea (n = 275)

26 (9.5)

10 (7.4)

16 (11.5)

0.24

Hypoxia (n = 444)

75 (20.4)

55 (15.8)

20 (20.6)

0.24

Normal physical exam

732 (97.6)

568 (97.3)

164 (98.8)

0.39

At least one abnormal finding below
Sick Looking

21 (2.4)

16 (2.7)

5 (1.2)

0.39

28 (37)

28 (4.8)

0 (0.0)

0.004

Abnormal lung sounds

92 (12.6)

59 (10.4)

33 (20.1)

0.001

Lungs wheezing

36 (4.9)

29 (5.1)

7 (4.3)

0.66

Abnormal mental status

b

Abnormal perfusion (n = 19)
Abnormal TM

c

81 (10.8)

71 (12.2)

10 (6.0)

0.02

12 (63.2)

12 (70.6)

0 (0.0)

0.12

155 (20.7)

110 (18.8)

45 (27.1)

0.02

Abnormal tonsils

380 (50.8)

283 (48.5)

97 (59.1)

0.02

Skin rash

38 (5.2)

34 (5.9)

4 (2.4)

0.07

85 (11.3)

72 (12.3)

13 (7.7)

0.09

Well appearing baby d

Percentages are of the total who had a response to that finding
a
Highest temperature measured in the Emergency Department
b
Includes hypoactivity, lethargy, sleepy, irritable
c
TM Tympanic membrane
d
normal physician exam and no symptoms other than congestion

group, the number of SBIs remained similar with no
statistical difference (p = 0.15). However, UTIs were statistically more common in the No-Antibiotic group (12.5
and 21.9%; p = 0.002 and 6.2 and 2.4%; p = 0.05, respectively) (Table 4). Our data on bacteremia and meningitis
were too few to analyze further. Since there were no

children < 90 days old on antibiotics, we did not do any
subgroup analysis for this age in this comparative study.

Discussion
Children presenting with antibiotics to the ED are usually excluded from studies on febrile children. Our study
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Table 2 Variables in the management/results associated with all patients 0–36 months of age presenting to the ED with fever,
previously on and off antibiotics
Management & results

All
N = 753

Any blood work, yes

ABN = 584

AB+
N = 169

P-Value

359 (47.7)

263 (45.0)

96 (56.8)

0.01

Blood WBC, mean(±SD)

13,468 ± 6363

13,324 ± 6318

13,865 ± 6502

0.48

Blood Neutrophils, mean(±SD)

53.1 ± 17.0

52.50 ± 16.93

54.58 ± 17.07

0.30

Blood Bands, mean(±SD)

0.7 ± 4.3

0.86 ± 4.97

0.09 ± 0.65

0.02

Blood lymphocytes, mean(±SD)

36.0 ± 16.1

36.48 ± 16.08

34.81 ± 16.24

0.39

Blood CRP, mean(±SD)

52.3 ± 68.7

52.35 ± 70.21

52.03 ± 65.11

0.97

Bacteremia (n = 156 for blood cultures)

4 (2.6)

2 (1.8)

2 (4.7)

0.31

168 (22.3)

133 (22.8)

35 (20.7)

0.57

Any urine test done, yes
Urine LE -positive

44 (27.3)

41 (31.8)

3 (9.4)

0.01

Urine Nitrites -positive

16 (9.9)

15 (11.6)

1 (3.1)

0.20

Urine bacteria -positive

29 (19.0)

25 (20.7)

4 (12.5)

0.30

Urine WBC -positive

33 (20.4)

31 (23.8)

2 (6.3)

0.03

40 (25.6)

36 (28.8)

4 (12.9)

0.07

207 (27.5)

144 (24.7)

63 (37.3)

0.001

UTI (n = 156 for urine cultures)
CXR done, yes
Positive/probable for pneumonia
Any CSF tested, yes

110 (53.1)

73 (50.7)

37 (58.7)

0.25

37 (4.9)

37 (6.3)

0 (0.0)

0.001

CSF WBC -positive

7 (25.9)

7 (25.9)

0 (0.0)

NA

CSF culture -positive

2 (5.9)

2 (5.9)

0 (0.0)

NA

Throat culture done, yes

59 (7.8)

39 (6.7)

20 (11.8)

0.03

4 (3.0)

4 (3.5)

0 (0.0)

1.00

68 (9.0)

46 (7.9)

22 (13.0)

0.04

1 (5.3)

1 (5.3)

0 (0.0)

NA

Throat culture - positive
Stool studies, yes
Stool culture -positive
Nasopharynx, yes

94 (16.1)

94 (16.1)

0 (0.0)

NA

RSV -positive

15 (34.1)

12 (36.4)

3 (27.3)

0.72

Flu -positive

13 (21.3)

13 (28.3)

0 (0.0)

0.03

266 (35.3)

212 (36.3)

54 (32.0)

0.30

None of the above testing done a
At least 1
None tested for SBI

b

At least 1 for SBI

487 (64.7)

372 (63.7)

115 (68.0)

543 (72.1)

427 (73.1)

116 (68.6)

0.25

210 (27.9)

157 (26.9)

53 (31.4)

Fluid bolus 20 ml/Kg, yes

82 (11.1)

60 (10.5)

22 (13.0)

0.35

Admission

154 (20.5)

121 (20.7)

34 (19.5)

0.74

a

testing done to look for signs of SBI or other infectious causes; WBC White blood cells, LE Leukocyte Esterase, UTI Urinary tract infection, CXR Chest Radiography,
CSF cerebrospinal fluid
b
Blood culture done, or Urine culture done, or CSF culture done

is the first to describe febrile children on antibiotics. In
our sample, a third of the febrile, healthy children presenting to the ED were already on antibiotics. These
were significantly different than the group off antibiotics
and were managed slightly differently. Interestingly, the
overall percentages of SBIs were similar in each group,
so were the admission and IV fluid bolus rates.
We found that older age, female gender, fever and abnormal lung sounds in the ED, were predictors of being
on antibiotics prior to the visit. In addition, we showed
that the antibiotic group had more focal infections

(lungs, tonsils, and ears) and was perhaps started on antibiotics for that reason; this may be explained by the
fact that upper respiratory infections (URTI) are the
most common reason for being on outpatient antibiotics
[20]. The No-Antibiotic group however did not have apparent focal infections but when they presented to the
ED, they were sicker. Yet our overall rate of at least one
SBI (Bacteremia, Meningitis and UTI) was 5.8% without
reaching any significant difference when comparing both
sub-groups on and off-antibiotics. This may be an
underestimation in the Antibiotic group if these affected
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Table 3 Multivariate analyses to identify the predictors of
presenting to the ED after being on antibiotic in the past 2
weeks
Antibiotic
OR (95% CI)

P-Value

Age (months)

1.04 (1.02–1.06)

< 0.001

Gender -Female

0.68 (0.47–0.98)

0.037

Height of fever in the ED, 38–39.4

0.47 (0.32–0.67)

< 0.001

Abnormal lung sounds

2.00 (1.23–3.25)

0.005

Variables included in the model were:
Age, Gender, Sore throat, Symptoms, Height of fever in the ED (reference: <
38), Abnormal lung sounds, Lungs wheezing, Abnormal mental status,
Abnormal Tympanic Membranes, Abnormal tonsils, Skin rash, Normal physical
exam, Well appearing baby (reference: no)

cultures; however, this also reflects the daily practice we
face in the ED. Given the similar rates of SBI in both
groups, and one study noting that antibiotics may in fact
prevent complications in certain infections such as
URTI, pharyngitis, otitis and hence have a protective effect [21], further studies looking at the clinical impact of
this antibiotic use are needed.
The most common source of antibiotic prescription in
our country remains the physician but only at 89.3%. It
is worth noting that our Lebanese pharmacies can still
issue an antibiotic without a prescription. This fits with
results from a recent Lebanese and Middle Eastern report that antibiotics were one of the most common
medications self-prescribed by patients [22, 23].
Finally, in our sample, the most common antibiotics used
were broad spectrum antibiotics, such as a 3rd generation
cephalosporin. As we noted that most patients on antibiotics
had abnormal lung sounds, tympanic membranes or tonsils,
perhaps these were to treat a pneumonia, otitis or Streptococcus tonsillitis. This is an interesting choice given the American
Academy of Pediatrics (AAP) guidelines to treat these primarily with Amoxicillin [24–26]. However, the use of a combined
penicillin/beta-lactam inhibitor does follow local patterns of
streptococcus pneumonia resistance to Amoxicillin [27, 28]
but is not justified for Streptococcus tonsillitis. In addition, it
is important to note that 10% had a parenteral form prescribed. Lack of adherence to antibiotic use guidelines has
already been documented in Lebanon [28, 29] The above

information on antibiotic use and misuse begs for national
campaigns for antibiotic stewardship including guidelines and
education A 2016 study of Lebanese hospitals showed that
only 7% knew what the term antimicrobial stewardship
meant, although around 65% reported having some type of
antibiotic control program in the hospital and only 50% had
an outcome measure in place [30]. However, in recent years,
The Lebanese Society of Infectious Diseases has published
several articles guiding the treatment of specific diseases such
as UTIs and complicated intraabdominal infections [31, 32].
.Moreover, the Alliance for the Prudent Use of Antibiotics
(APUA) has a Lebanese chapter that has been active especially in antibiotic stewardship education [33], braving the
first steps to promoting antibiotic stewardship programs in
the country; steps that other nations with a similar pattern of
antibiotic use should also follow.

Limitation
In this retrospective study our data is limited by the accuracy and completeness of the medical records, therefore no inferences were made on immunization and vital
signs because of this. We don’t have the exact timing of
the laboratory draws, but all reported laboratory results
were done during the sentinel ED visit. We also do not
have information on the duration of antibiotic pretreatment, nor why it was given and therefore cannot determine its exact impact on cultures and laboratory results.
In addition, the SBI rates of the pretreated group may be
underreported as the antibiotics could have influenced
the culture results. However, this reflects the reality of
our clinical practice and decisions we have to make.
Conclusions
In conclusion, this is the first study of its kind to describe febrile children already on antibiotics presenting
to the ED compared to those not on antibiotics. It generated interesting preliminary data that opens doors to
further investigations on predictors for testing febrile patients on antibiotics, on understanding how to interpret
the test results and more importantly to understand predictors of SBI and SBI outcomes in this group.

Table 4 Number of Serious Bacterial Infection (SBI) in all patients 0–36 months of age, tested or not for SBI
SBI variable

All
N = 753

ABN = 584

AB+
N = 169

P-Value

Urinary Tract Infection -positive

40 (5.3)

36 (6.2)

4 (2.4)

0.05

Bacteremia -positive

4 (0.5)

2 (0.3)

2 (1.2)

0.22

Meningitis -positive

2 (0.3)

2 (0.3)

0 (0.0)

1.00

Negative for any SBI

709 (94.2)

546 (93.5)

163 (96.4)

0.15

At least 1 SBI positive

44 (5.8)

38 (6.5)

6 (3.6)
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